Frigate Ventures »

Oncolytics Biotech shares owned by Frigate Ventures

Quarter-by-quarter ownership of Oncolytics Biotech (ONCY) shares owned by Frigate Ventures from 13F filings

Historical chart of Frigate Ventures investment in Oncolytics Biotech

Tip: Access up to 7 years of quarterly data

All positions including Oncolytics Biotech held by Frigate Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncolytics Biotech by Frigate Ventures

Quarter filed Position value Share count Share price at filing
2023-09-30 $12M 5.3M 2.18

More positions owned by Frigate Ventures

Tempur Sealy International Equity (TPX)
AdvisorShares Pure US Cannabis ETF Exchange Traded Fund (MSOS)
Nano Dimension Adr (NNDM)
Blockchain Coinvestors Acquisition Corp I Warrant (BCSAW)
iShares U.S. Real Estate ETF Exchange Traded Fund (IYR)
iShares 20 Year Treasury Bond ETF Option Call Option (TLT)
SPDR S&P 500 ETF Trust Option Put Option (SPY)
iShares iBoxx High Yield Corporate Bond ETF Option Put Option (HYG)
Block Option Call Option (SQ)
Activision Blizzard Equity
Oncolytics Biotech Equity (ONCY)
Vivid Seats Equity (SEAT)
iShares China Large-Cap ETF Option Call Option (FXI)
Invesco QQQ Trust Series 1 Option Put Option (QQQ)
Tricon Residential Option Call Option (TCN)

View all positions for Frigate Ventures

Top funds holding Oncolytics Biotech

International Assets Investment Management
Millennium Management
Citadel Advisors
Commonwealth Equity Services
Royal Bank of Canada
Long Focus Capital Management
Bank Of Montreal
Ausdal Financial Partners
Brave Asset Management
Two Sigma Securities
Newman Dignan & Sheerar
C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors
Banque Cantonale Vaudoise
Headinvest
Jpmorgan Chase & Co

View all funds holding Oncolytics Biotech